These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 35963443)

  • 1. Mobile app-based symptom-rhythm correlation assessment in patients with persistent atrial fibrillation.
    Hermans ANL; Gawalko M; Slegers DPJ; Andelfinger N; Pluymaekers NAHA; Verhaert DVM; van der Velden RMJ; Betz K; Evens S; Luermans JGLM; den Uijl DW; Baumert M; Nguyen HL; Isaksen JL; Kanters JK; Rienstra M; Vernooy K; Van Gelder IC; Hendriks JM; Linz D
    Int J Cardiol; 2022 Nov; 367():29-37. PubMed ID: 35963443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The RITMIA™ Smartphone App for Automated Detection of Atrial Fibrillation: Accuracy in Consecutive Patients Undergoing Elective Electrical Cardioversion.
    Reverberi C; Rabia G; De Rosa F; Bosi D; Botti A; Benatti G
    Biomed Res Int; 2019; 2019():4861951. PubMed ID: 31355264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardioversion of persistent atrial fibrillation is associated with a 24-hour relapse gap: Observations from prolonged postcardioversion rhythm monitoring.
    Weijs B; Limantoro I; Delhaas T; de Vos CB; Blaauw Y; Houben RPM; Verheule S; Pisters R; Crijns HJGM
    Clin Cardiol; 2018 Mar; 41(3):366-371. PubMed ID: 29569353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors, management, and outcome of cardioversion failure early after atrial fibrillation ablation.
    Ebert M; Stegmann C; Kosiuk J; Dinov B; Richter S; Arya A; Müssigbrodt A; Sommer P; Hindricks G; Bollmann A
    Europace; 2018 Sep; 20(9):1428-1434. PubMed ID: 29165582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical utility of rhythm control by electrical cardioversion to assess the association between self-reported symptoms and rhythm status in patients with persistent atrial fibrillation.
    Hermans ANL; Pluymaekers NAHA; Lankveld TAR; van Mourik MJW; Zeemering S; Dinh T; den Uijl DW; Luermans JGLM; Vernooy K; Crijns HJGM; Schotten U; Linz D
    Int J Cardiol Heart Vasc; 2021 Oct; 36():100870. PubMed ID: 34568541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clustering of RR intervals predicts effective electrical cardioversion for atrial fibrillation.
    Van Den Berg MP; Van Noord T; Brouwer J; Haaksma J; Van Veldhuisen DJ; Crijns HJ; Van Gelder IC
    J Cardiovasc Electrophysiol; 2004 Sep; 15(9):1027-33. PubMed ID: 15363075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PULSE-SMART: Pulse-Based Arrhythmia Discrimination Using a Novel Smartphone Application.
    McMANUS DD; Chong JW; Soni A; Saczynski JS; Esa N; Napolitano C; Darling CE; Boyer E; Rosen RK; Floyd KC; Chon KH
    J Cardiovasc Electrophysiol; 2016 Jan; 27(1):51-7. PubMed ID: 26391728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Demographic and clinical characteristics of patients with atrial fibrillation and cardioversion as planned therapeutic options in the International Registry on Cardioversion of Atrial Fibrillation RHYTHM-AF Polish substudy.
    Dąbrowski R; Opolski G; Włodarczyk P; Kiliszek M; Ponikowski P
    Kardiol Pol; 2014; 72(8):700-6. PubMed ID: 24671916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mechanical fibrillation pattern of the atrial myocardium is associated with acute and long-term success of electrical cardioversion in patients with persistent atrial fibrillation.
    De Vos CB; Limantoro I; Pisters R; Delhaas T; Schotten U; Cheriex EC; Tieleman RG; Crijns HJ
    Heart Rhythm; 2014 Sep; 11(9):1514-21. PubMed ID: 24768608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mobile Photoplethysmographic Technology to Detect Atrial Fibrillation.
    Guo Y; Wang H; Zhang H; Liu T; Liang Z; Xia Y; Yan L; Xing Y; Shi H; Li S; Liu Y; Liu F; Feng M; Chen Y; Lip GYH;
    J Am Coll Cardiol; 2019 Nov; 74(19):2365-2375. PubMed ID: 31487545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heart rate variability and recurrence of atrial fibrillation after electrical cardioversion.
    Vikman S; Mäkikallio TH; Yli-Mäyry S; Nurmi M; Airaksinen KE; Huikuri HV
    Ann Med; 2003; 35(1):36-42. PubMed ID: 12693611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic Accuracy of a Novel Mobile Phone Application for the Detection and Monitoring of Atrial Fibrillation.
    Rozen G; Vaid J; Hosseini SM; Kaadan MI; Rafael A; Roka A; Poh YC; Poh MZ; Heist EK; Ruskin JN
    Am J Cardiol; 2018 May; 121(10):1187-1191. PubMed ID: 29525063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors predicting success rate and recurrence of atrial fibrillation after first electrical cardioversion in patients with persistent atrial fibrillation.
    Frick M; Frykman V; Jensen-Urstad M; Ostergren J; Rosenqvist M
    Clin Cardiol; 2001 Mar; 24(3):238-44. PubMed ID: 11288971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin II blockade, YKL-40 and maintenance of sinus rhythm after electrical cardioversion for atrial fibrillation.
    Tveit A; Seljeflot I; Smith P; Arnesen H; Svendsen JH
    Immunobiology; 2013 Oct; 218(10):1256-60. PubMed ID: 23731775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epicardial fat thickness: A new predictor of successful electrical cardioversion and atrial fibrillation recurrence.
    Dereli S; Bayramoğlu A; Yontar OC; Cerşit S; Gürsoy MO
    Echocardiography; 2018 Dec; 35(12):1926-1931. PubMed ID: 30387182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of electrical cardioversion on quality of life for patients with symptomatic persistent atrial fibrillation: Is there a treatment expectation effect?
    Ha ACT; Stewart J; Klein G; Roy D; Connolly S; Koren A; Dorian P
    Am Heart J; 2020 Aug; 226():152-160. PubMed ID: 32580074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Echocardiographic assessment of left atrial morphology and function to predict maintenance of sinus rhythm after electrical cardioversion in patients with non-valvular persistent atrial fibrillation and normal function or mild dysfunction of left ventricle.
    Wałek P; Sielski J; Starzyk K; Gorczyca I; Roskal-Wałek J; Wożakowska-Kapłon B
    Cardiol J; 2020; 27(3):246-253. PubMed ID: 31313277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrent atrial fibrillation/flutter detection after ablation or cardioversion using the AliveCor KardiaMobile device: iHEART results.
    Goldenthal IL; Sciacca RR; Riga T; Bakken S; Baumeister M; Biviano AB; Dizon JM; Wang D; Wang KC; Whang W; Hickey KT; Garan H
    J Cardiovasc Electrophysiol; 2019 Nov; 30(11):2220-2228. PubMed ID: 31507001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of platelet to lymphocyte ratio for predicting recurrence of atrial fibrillation after direct current cardioversion.
    Dereli S; Bayramoğlu A; Yontar OC
    Ann Noninvasive Electrocardiol; 2019 Mar; 24(2):e12616. PubMed ID: 30414335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reverse atrial remodeling in patients who maintain sinus rhythm after electrical cardioversion: evidence derived from the measurement of total atrial conduction time assessed by PA-TDI interval.
    Müller P; Schiedat F; Dietrich JW; Shin DI; Kara K; Mügge A; Deneke T
    J Echocardiogr; 2014 Dec; 12(4):142-50. PubMed ID: 27277168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.